Bri-Chem Corp. is experiencing a notable drop in its stock price, causing concern among investors about its future.
In the latest trading session, Bri-Chem Corp. (BRY.TO) saw its stock price fall by 6.06%, closing at CA$0.31. This decline adds to the worries for a company already facing challenges with decreasing sales and market confidence.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Bri-Chem Corp.
BRY.TO
BRY.TO
Bri-Chem Corp.
WealthAwesomeMarket cap
$9.25M
P/E
5.0x
52W high
$0.44
52W low
$0.20
1W change
+14.75%
Beta
-0.76
Analyst Price Targets
Based on analyst covering BRY
Wall Street analysts forecast BRY stock price to fall 37.1% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.22
-37.1% Upside
Current Price
C$0.35
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BRY's historical volatility
30-Day Vol
88.8%
Annualized
90-Day Vol
75.6%
Annualized
Trend (90d)
-17.6%
Annualized drift
90d Mean
C$0.33
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.34 | C$0.25 โ C$0.47 |
| 60 trading days | C$0.34 | C$0.22 โ C$0.52 |
| 90 trading days | C$0.33 | C$0.19 โ C$0.56 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Keep an eye on Bri-Chem's performance and consider the implications of its recent financial results and leadership changes.
Bri-Chem Corp. stock down 6.06% in one day
With a market cap of CA$8.19 million and a P/E ratio of 4.43, Bri-Chem's financial health is under scrutiny as it deals with declining sales figures.
Bull case
If Bri-Chem can effectively utilize its recent supply agreement with Reliant Technologies to improve its product offerings, it might reverse its sales decline and boost investor confidence.
Bear case
Ongoing sales drops and unclear strategic direction under new leadership could further shake investor confidence and lead to more declines in stock price.
Recent Performance Overview
Bri-Chem Corp.'s stock closed down 6.06% yesterday, a significant drop that reflects investor concerns over the company's ongoing sales challenges. With a market cap of CA$8.19 million, the company is facing increasing scrutiny as it struggles to maintain profitability amid declining sales.
Financial Health and Market Sentiment
The company's recent financial results have not been encouraging. Bri-Chem reported a 9% decrease in annual sales to CA$75.6 million and an 18% drop in fourth-quarter sales. Investors are likely worried about what these figures mean for the company's future, especially with a P/E ratio of 4.43 suggesting potential undervaluation but also risk.
What Lies Ahead for Bri-Chem?
As Bri-Chem works through these challenges, the recent appointment of Barry Hugghins as CEO may introduce new strategies. However, investors should stay cautious, as the company's recovery depends on how well it executes new agreements and its overall market strategy. For more insights, visit our Bri-Chem Corp. stock page.
Advertisement
